News & Press Releases
- News
Kongsberg Beam Technology has been awarded second prize in the pitching session at Norway Life Science 2023
- February 15, 2023
- News
Kongsberg Beam Technology selected to pitch at the DNB Nordic Healthcare Conference 2022
- December 8, 2022
- Press Release
Kongsberg Beam Technology appoints Stephan Dymling as new Chief Technology Officer
- July 4, 2022
- Press Release
Japan Patent Office grants patent for Kongsberg Beam Technology’s system design of MaMa-K™
- June 15, 2022
- Podcast
Podcast Teknisk sett by Teknisk Ukeblad – Skal gjøre bestrålning av kreftsvulster mer presise
- June 2, 2022
- Press Release
Kongsberg Beam Technology raises NOK ~ 10 million for the product development of MaMa-K™ to reduce side effects in radiation therapy
- May 31, 2022
Articles
Skal hente opptil 20 millioner kroner
Skuddpremie på bivirkninger
Experienced CEO joins Kongsberg Beam Technology
Kongsberg Hentet inn 13 millioner
Kreftceller i sikte
Studying medtech with cancer patients at heart
Semcon responsible for development of revolutionary cancer treatment
Fikk 22,7 millioner av Forskningsrådet
Skal drepe kreftceller mer effektivt med industriell ammunisjon
Per Håvards idé kan bli verdensnyhet
Pressroom
Boilerplate
About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K™ can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.
Images for download
Logotypes for download
